JACOBSON PHARMA (02633.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov18

Jacobson Pharma released FY2026 Q1 earnings on November 18, 2025 (BJT) with actual revenue of HKD 383.28 M and EPS of HKD 0.0356

15:00

Jacobson Pharma released FY2026 Q2 earnings on November 18 Pre-Market BJT, actual revenue HKD 383.28 M, actual EPS HKD 0.0355

01:00

Jacobson Pharma released FY2026 Semi-Annual Earnings on November 18 Pre-Market (BJT), with actual revenue of HKD 766.55 M and EPS of HKD 0.0711

01:00

Nov10

Jacobson Pharma to Release FY2026 Semi-Annual Earnings on November 18, 2025 (BJT)

00:09

Oct28

Jacobsen and Jianbeimiao Subsidiaries Sign Factory Usage Licensing Agreement

10:48

Jacob 臣 Scientific Pharmaceuticals Signs New 2025 Europharm Licensing Agreement

10:33

Schedules & Filings

Schedules

Filings

Dec18

Distribution Plan(CST)

Cash dividend 0.0425 HKD

Dec2

Distribution Plan(CST)

Cash dividend 0.0425 HKD

Dec1

Distribution Plan(CST)

Cash dividend 0.0425 HKD

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More